Investment Analysts’ Upgrades for July, 17th (SFLY, SGMO, SHI, SLDB, SLS, SOMLY, SPAR, SPCB, SRNE, SRRK)

Investment Analysts’ upgrades for Wednesday, July 17th:

Shutterfly (NASDAQ:SFLY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $53.00 target price on the stock. According to Zacks, “Shares of Shutterfly have underperformed the industry in the past six months. Although the company reported better-than-expected results in first-quarter 2019, soft consumer growth is a major concern. Further, earnings estimates for the current quarter and year have witnessed sharp downward revisions over the past 60 days, reflecting analysts’ concern on the company’s earnings prospects. Shutterfly anticipates moderated consumer growth in the near term as well. This prompted management to lower adjusted EBITDA growth expectation for the next three year. However, Shutterfly’s focus on improving operational efficiency through major restructuring bodes well. Continual product innovations and focus on improving technology-related offerings are added positives. The company also continues to launch personalized gifts and home décor to attract customers.”

Sangamo Therapeutics (NASDAQ:SGMO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company’s product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States. “

Sinopec Shanghai Petrochemical (NYSE:SHI) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $43.00 target price on the stock. According to Zacks, “Shanghai Petrochemical Company Ltd. is a China’s largest petrochemical company. The Company processes crude oil into synthetic fibers, resins and plastics, intermediate petrochemicals and petroleum products. “

Solid Biosciences (NASDAQ:SLDB) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Solid Biosciences LLC is a life science company. It focuses on developing therapies for Duchenne muscular dystrophy. The company is engaged in developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its product candidate includes SGT-001, a gene transfer candidate which is in Phase I/II clinical trial to restore functional dystrophin protein expression in patients’ muscles. Solid Biosciences LLC is headquartered in Cambridge, Massachusetts. “

SLS International (AMEX:SLS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company’s product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States. “

SECOM LTD/ADR (OTCMKTS:SOMLY) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Secom Co. Ltd. is a security company, providing its services to a number of corporate and individual clients. It conducts consistent management from research and development to manufacturing of equipment, installation work, monitoring, and emergency measures by security guards. For individual clients, various sensors are installed in their home to detect intrusions, fires, emergency situations, gas leaks, medical emergencies and other problems, and automatically notify the SECOM control center when they are detected. Products for corporate clients include access-control systems, closed-circuit television (CCTV) systems, automated fire detection and extinguishing systems, and internal and external monitoring systems that can be used alone or connected to on-line security systems. The Company also provides static guard service and armored car services. Secom Co. Ltd. is headquartered in Tokyo, Japan. “

Spartan Motors (NASDAQ:SPAR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $11.00 target price on the stock. According to Zacks, “Spartan is a leading designer, engineer and manufacturer of custom heavy-duty chassis. The Company’s chassis consist of a frame assembly, engine, transmission, electrical systems, running gear (wheels, tires, axles, suspension and brakes) and, for some applications, a cab. The Company’s customers are original equipment manufacturers (OEMs) who complete their vehicle product by mounting the body or apparatus on a Spartan chassis. “

SuperCom (NASDAQ:SPCB) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “SuperCom Ltd. is a provider of radio frequency identification solutions. It offers advanced safety, identification and security products and solutions primarily to Governments, private and public organizations. The Company produces systems for viewing, tracking, locating, credentialing, and managing assets and personnel. SuperCom Ltd., formerly known as Vuance Ltd., is headquartered in Qadima, Israel. “

Sorrento Therapeutics (NASDAQ:SRNE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California. “

Scholar Rock (NASDAQ:SRRK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $16.00 price target on the stock. According to Zacks, “Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company’s product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States. “

Southwest Gas (NYSE:SWX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $100.00 target price on the stock. According to Zacks, “Southwest Gas Holdings, Inc. is an energy holding company based in Las Vegas, Nevada. Southwest Gas Holdings, Inc. owns two primary operating companies, Southwest Gas Corporation and Centuri Construction Group, Inc. Southwest Gas Corporation is a regulated utility and provides natural gas service to more than 1.9 million residential, commercial, and industrial customers in most of Arizona and Nevada, and parts of northeastern and southeastern California. Centuri Construction Group, Inc., is a full-service underground piping contractor that primarily provides utility companies with trenching and installation, replacement, and maintenance services for energy distribution systems, and develops industrial construction solutions. Centuri Construction Group Inc. operates in major markets across the United States and Canada. “

Takeda Pharmaceutical (NYSE:TAK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $20.00 target price on the stock. According to Zacks, “Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda’s core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan. “

Tate & Lyle (OTCMKTS:TATYY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. “

Tecogen (NASDAQ:TGEN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Tecogen Inc. designs, manufactures, sells, and services systems that produce electricity, hot water, and air conditioning for commercial installations and buildings and industrial processes. The Company’s ultra-efficient products include cogeneration modules, which provide electricity and heat, and chillers, which provide air-conditioning and optional free hot water. Its products supply electrical power or mechanical power for cooling, as well as free engine heat that gets recovered and purposefully used at customer facilities. Tecogen Inc. is based in United States. “

Textainer Group (NYSE:TGH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $11.00 target price on the stock. According to Zacks, “TEXTAINER GROUP is the worlds largest lessor of intermodal containers with a total fleet of more than 1.3 million containers, representing over 2,000,000 TEU. They lease containers to more than 400 shipping lines and other lessees, including each of the world’s top 20 container lines. Yhey are also the primary supplier of leased containers to the U.S. Military. Their goal is to be the most reliable lessor of containers in locations where their customers need them. They have provided an average of more than 100,000 TEU of new containers per year for the past 10 years, and have been one of the largest purchasers of new containers among container lessors over the same period. They are also one of the largest sellers of used containers , having sold an average of more than 53,000 containers per year for the last five years. “

Receive News & Ratings for Shutterfly Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shutterfly Inc and related companies with MarketBeat.com's FREE daily email newsletter.